Cargando…

ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications

PURPOSE: The antitumoral effect of ATP requires its accumulation in the extracellular space to interact with membrane receptors in target cells. We propose the use of albumin nanoparticles (ANPs) coated with erythrocyte membranes (EMs) to load, deliver, release, and enhance the extracellular antican...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Saldívar, Patricia, Huidobro-Toro, Juan Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454990/
https://www.ncbi.nlm.nih.gov/pubmed/31040666
http://dx.doi.org/10.2147/IJN.S192925
_version_ 1783409638663782400
author Díaz-Saldívar, Patricia
Huidobro-Toro, Juan Pablo
author_facet Díaz-Saldívar, Patricia
Huidobro-Toro, Juan Pablo
author_sort Díaz-Saldívar, Patricia
collection PubMed
description PURPOSE: The antitumoral effect of ATP requires its accumulation in the extracellular space to interact with membrane receptors in target cells. We propose the use of albumin nanoparticles (ANPs) coated with erythrocyte membranes (EMs) to load, deliver, release, and enhance the extracellular anticancer activity of ATP. MATERIALS AND METHODS: ANPs were synthesized by desolvation method and optimal values of pH, albumin concentration, and ethanol volume were determined. EMs were derived from erythrocyte lysates and were coated on to ANPs using an extruder. Size was determined by transmission electron microscopy (TEM) and hydrodynamic size and zeta potential were determined by dynamic light scattering. Coating of the ANPs with the EMs was verified by TEM and confocal microscopy. Nanoparticle cell uptake was analyzed by confocal microscopy using HeLa and HEK-293 cell cultures treated with nanoparticles stained with 1,1′-diocta-decyl-3,3,3′,3′-tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt (DiD) for EM-ANPs and Alexa 488 for ANPs. Cell viability was analyzed by [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) and Annexin V/propidium iodide assays. RESULTS: Optimal values of ANP preparation were as follows: pH=9, 10 mg/mL albumin concentration, and 2.33±0.04 mL ethanol volume. Size distributions as analyzed by TEM were as follows: ANPs =91.9±4.3 nm and EM-ANPs =98.3±5.1 nm; hydrodynamic sizes: ANPs =180.5±6.8 nm and EM-ANPs =197.8±3.2 nm; and zeta potentials: ANPs =17.8±3.5 mV, ANPs+ATP =−13.60±0.48 and EM-ANPs =−13.7±2.9 mV. The EMs coating the ANPs were observed by TEM and confocal microscopy. A fewer number of internalized EM-ANPs+ATP compared to non-coated ANPs+ATP was observed in HeLa and HEK-293 cells. Cell viability decreased up to 48.6%±2.0% with a concentration of 400 µM ATP after 72 hours of treatment and cell death is caused mainly via apoptosis. CONCLUSION: Our current results show that it is possible to obtain nanoparticles from highly biocompatible, biodegradable materials and that their coating with EMs allows the regulation of the internalization process in order to promote extracellular activity of ATP.
format Online
Article
Text
id pubmed-6454990
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64549902019-04-30 ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications Díaz-Saldívar, Patricia Huidobro-Toro, Juan Pablo Int J Nanomedicine Original Research PURPOSE: The antitumoral effect of ATP requires its accumulation in the extracellular space to interact with membrane receptors in target cells. We propose the use of albumin nanoparticles (ANPs) coated with erythrocyte membranes (EMs) to load, deliver, release, and enhance the extracellular anticancer activity of ATP. MATERIALS AND METHODS: ANPs were synthesized by desolvation method and optimal values of pH, albumin concentration, and ethanol volume were determined. EMs were derived from erythrocyte lysates and were coated on to ANPs using an extruder. Size was determined by transmission electron microscopy (TEM) and hydrodynamic size and zeta potential were determined by dynamic light scattering. Coating of the ANPs with the EMs was verified by TEM and confocal microscopy. Nanoparticle cell uptake was analyzed by confocal microscopy using HeLa and HEK-293 cell cultures treated with nanoparticles stained with 1,1′-diocta-decyl-3,3,3′,3′-tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt (DiD) for EM-ANPs and Alexa 488 for ANPs. Cell viability was analyzed by [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) and Annexin V/propidium iodide assays. RESULTS: Optimal values of ANP preparation were as follows: pH=9, 10 mg/mL albumin concentration, and 2.33±0.04 mL ethanol volume. Size distributions as analyzed by TEM were as follows: ANPs =91.9±4.3 nm and EM-ANPs =98.3±5.1 nm; hydrodynamic sizes: ANPs =180.5±6.8 nm and EM-ANPs =197.8±3.2 nm; and zeta potentials: ANPs =17.8±3.5 mV, ANPs+ATP =−13.60±0.48 and EM-ANPs =−13.7±2.9 mV. The EMs coating the ANPs were observed by TEM and confocal microscopy. A fewer number of internalized EM-ANPs+ATP compared to non-coated ANPs+ATP was observed in HeLa and HEK-293 cells. Cell viability decreased up to 48.6%±2.0% with a concentration of 400 µM ATP after 72 hours of treatment and cell death is caused mainly via apoptosis. CONCLUSION: Our current results show that it is possible to obtain nanoparticles from highly biocompatible, biodegradable materials and that their coating with EMs allows the regulation of the internalization process in order to promote extracellular activity of ATP. Dove Medical Press 2019-04-05 /pmc/articles/PMC6454990/ /pubmed/31040666 http://dx.doi.org/10.2147/IJN.S192925 Text en © 2019 Díaz-Saldívar and Huidobro-Toro. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Díaz-Saldívar, Patricia
Huidobro-Toro, Juan Pablo
ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
title ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
title_full ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
title_fullStr ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
title_full_unstemmed ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
title_short ATP-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
title_sort atp-loaded biomimetic nanoparticles as controlled release system for extracellular drugs in cancer applications
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454990/
https://www.ncbi.nlm.nih.gov/pubmed/31040666
http://dx.doi.org/10.2147/IJN.S192925
work_keys_str_mv AT diazsaldivarpatricia atploadedbiomimeticnanoparticlesascontrolledreleasesystemforextracellulardrugsincancerapplications
AT huidobrotorojuanpablo atploadedbiomimeticnanoparticlesascontrolledreleasesystemforextracellulardrugsincancerapplications